 | |
| Clinical data | |
|---|---|
| Trade names | Simparica |
| Other names | PF-6450567 |
| ATCvet code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| ECHA InfoCard | 100.234.000 |
| Chemical and physical data | |
| Formula | C23H18Cl2F4N2O5S |
| Molar mass | 581.36 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Sarolaner, sold under the brand name Simparica, is an ectoparasiticide veterinary medication for the treatment of flea and tick infestations in dogs.[3][4] It is also used off-label to control sarcoptic mange and demodectic mange.[4]
Sarolaner is also a component of the combination drug Simparica Trio, which contains sarolaner, moxidectin, and pyrantel.[5] It is used for prevention of heartworm disease caused by Dirofilaria immitis; treat and prevent flea infestations; treat and control tick infestations with the lone star tick, Gulf Coast tick, American dog tick, black-legged tick, and brown dog tick; and treat and control roundworm and adult hookworm infections.[6]
Sarolaner is also an ingredient in feline combination antiparasitic Revolution Plus (or Stronghold Plus[7]), which contains sarolaner and selamectin and is used for prevention of sarcoptic mange, feline hookworms, feline roundworms, ear mites, and heartworms, as well as treating and preventing fleas and ticks.[8]
References
- ^ "Approved in 2020: Drugs for human use". Health Canada. 26 July 2021. Retrieved 27 March 2024.
- ^ "Simparica". U.S. Food and Drug Administration (FDA). Retrieved 12 December 2022.
- ^ McTier TL, Chubb N, Curtis MP, Hedges L, Inskeep GA, Knauer CS, et al. (May 2016). "Discovery of sarolaner: A novel, orally administered, broad-spectrum, isoxazoline ectoparasiticide for dogs" (PDF). Veterinary Parasitology. 222: 3–11. doi:10.1016/j.vetpar.2016.02.019. PMID 26961590.
- ^ a b Gollakner R. "Sarolaner". vcahospitals.com. VCA Hospitals. Retrieved 26 June 2021.
- ^ "Simparica Trio". U.S. Food and Drug Administration (FDA). Retrieved 12 December 2022.
- ^ "FDA Approves Simparica Trio, a Combination Drug for Heartworm and Other Parasites". U.S. Food and Drug Administration (FDA). 2 March 2020. Retrieved 26 June 2021.
- ^ "Stronghold Plus". European Medicines Agency. Retrieved 12 December 2022.
- ^ "Revolution Plus". U.S. Food and Drug Administration (FDA). Retrieved 12 December 2022.
External links
- "Sarolaner". Drug Information Portal. U.S. National Library of Medicine.
 | This veterinary medicine–related article is a stub. You can help Wikipedia by expanding it. |
 | This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |
This page was last edited on 28 March 2024, at 23:58